Fundraising FoxEmerald Therapeutics
Menlo Park, US · Founded 2009 · 2 known investors
Find your way into Emerald Therapeutics
Sign up to see every warm intro you have to Emerald Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Emerald Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Emerald Therapeutics was founded in 2009 by Brian Frezza and Daniel J. Kleinbaum.
BF
Brian FrezzaCo-founder2010–2025Brian Frezza holds a PhD in Chemical Biology from The Scripps Research Institute, where he worked on DNA nanotechnology. He is the lead architect of Emerald Cloud Lab, a web-based platform for remote wet lab experimentation and management, and leads the company's antiviral research efforts.
DJ
Daniel J. KleinbaumCo-founder
Board
MR
Max R. LevchinBoard director
LN
Luke NosekBoard director
Investors · 2
Founders FundreportedSan Francisco · $500K – $5M
How we know: funding news · Not right? Tell us
Schooner CapitalreportedBoston
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$6.6M disclosed across 2 rounds · 2012–2014
▶$5.6MraisedFeb 2014 · 5 investors · Other Health CareRule 506(b)
▶$5.6MraisedFeb 2014 · 5 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Daniel J. KleinbaumExecutive Officer, Director
- Brian SingermanDirector
- Max R. LevchinDirector
- Brian FrezzaExecutive Officer, Director
- Offering amount
- $6M
- Amount sold
- $5.6M
- First sale
- Feb 2014
- Incorporated
- Corporation, Delaware, 2009
- Federal exemptions
- 06b
▶$1MraisedMar 2012 · 4 investors · Other Health CareRule 506(b)
▶$1MraisedMar 2012 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Brian FrezzaExecutive Officer, Director
- Daniel J. KleinbaumExecutive Officer, Director
- Max R. LevchinDirector
- Luke NosekDirector
- Offering amount
- $2.9M
- Amount sold
- $1M
- First sale
- Mar 2012
- Incorporated
- Corporation, Delaware, 2009
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Emerald Therapeutics?
- Emerald Therapeutics was founded by Brian Frezza, Daniel J. Kleinbaum in 2009.
- Who are Emerald Therapeutics's investors?
- Emerald Therapeutics's investors include Founders Fund, Schooner Capital.
- How much funding has Emerald Therapeutics raised?
- Emerald Therapeutics has disclosed $6.6M raised across 2 rounds.
- Where is Emerald Therapeutics headquartered?
- Emerald Therapeutics is headquartered in Menlo Park, US.